PK Study of Dapagliflozin in Pediatric Subjects with T2DM - Trial 2011-005225-40

Name: Clinical Trial 2011-005225-40
Creator: Bristol-Myers Squibb Company
Keywords: Type 2 diabetes mellitus, clinical trial

Access comprehensive clinical trial information for 2011-005225-40 through Pure Global AI's free database. This phase not specified trial is sponsored by Bristol-Myers Squibb Company and is currently status unknown. The study focuses on Type 2 diabetes mellitus.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database

840K+ Trials

2011-005225-40

Trial Details

EU Clinical Trials Register • 2011-005225-40

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

PK Study of Dapagliflozin in Pediatric Subjects with T2DM

Study Focus

Disease/Condition

Type 2 diabetes mellitus

Sponsor & Location

Primary Sponsor

Bristol-Myers Squibb Company

Timeline & Enrollment

Phase

N/A

Start Date

N/A

End Date

N/A

Primary Outcome

• Fasting plasma glucose (FPG) > 240 mg/dL at screening

ICD-10 Classifications

Type 2 diabetes mellitus

Type 2 diabetes mellitus with unspecified complications

Type 2 diabetes mellitus with other specified complications

Type 2 diabetes mellitus without complications

Type 2 diabetes mellitus with multiple complications

Data Source

Registry

EU Clinical Trials Register

Trial ID

2011-005225-40

Type

Non-Device Trial